false
--12-31
0001114483
0001114483
2026-11-17
2026-11-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K
____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event
reported): November 17, 2026

INTEGER HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
____________________________
| Delaware |
|
1-16137 |
|
16-1531026 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
| 5830 Granite Parkway, Suite 1150 |
|
Plano, Texas |
|
75024 |
| (Address of principal executive offices) |
|
(Zip Code) |
(214) 618-5243
Registrant’s telephone number, including area code
____________________________
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $0.001 par value per share |
|
ITGR |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
INTRODUCTORY NOTE
This Current Report on Form 8-K is being filed
in connection with the completion on November 17, 2026 (the “Closing Date”) of the previously announced acquisition by Armstrong
Parent, Inc., a Delaware corporation (“Parent”), of Integer Holdings Corporation, a Delaware corporation (“Integer”
or the “Company”), pursuant to the Agreement and Plan of Merger (the “Merger Agreement,” and the transactions
contemplated thereby, the “Transaction”), dated as of August 2, 2026, by and among Integer, Parent and Armstrong Bidco, Inc.,
a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).
Pursuant to the Merger Agreement, and upon the terms and conditions
therein, on the Closing Date, Merger Sub merged with and into Integer and Integer continued as the surviving corporation and wholly owned
subsidiary of Parent (the “Merger”). Parent and Merger Sub are each affiliates of investment funds managed by Kohlberg Kravis
Roberts & Co. L.P., a leading global investment firm.
Item 1.01 Entry into a Material Definitive Agreement
The information set forth in the Introductory Note to this Current
Report on Form 8-K (the “Introductory Note”) is incorporated into this Item 1.01 by reference.
Financing; New Credit Agreement
On the Closing Date, Parent, as holdings (in such capacity, “Holdings”),
Merger Sub, as the initial borrower (in such capacity, the “Initial Borrower”), and the Company (immediately following the
consummation of the Merger, as successor to the Initial Borrower, the “Borrower”) entered into that certain Credit Agreement
with Citibank, N.A., as administrative agent and collateral agent, and the lenders and letter of credit issuers from time to time party
thereto (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). The Credit Agreement
provides for extensions of credit in the form of (i) initial term loans to the Borrower in an aggregate principal amount of $2,100,000,000
(the “Initial Term Loans”), (ii) revolving credit loans made available to the Borrower at any time and from time to time in
an aggregate principal amount at any time outstanding not to exceed $350,000,000 (including letter of credit extensions and swingline
loans, described below), (iii) letters of credit from time to time in an aggregate stated amount at any time outstanding not to exceed
$87,500,000, and (iv) swingline loans in an aggregate principal amount at any time outstanding not to exceed $75,000,000. The obligations
under the Credit Agreement are guaranteed by Holdings and certain subsidiaries of the Borrower and are secured on a first priority basis
by substantially all assets of the Borrower and the guarantors (in each case, subject to certain exclusions and exceptions). The Credit
Agreement includes representations and warranties, covenants, events of default and other provisions that are customary for facilities
of this type.
New Supplemental Indentures
On the Closing Date, the Company entered into (i) the First Supplemental
Indenture, dated as of the Closing Date (the “2028 First Supplemental Indenture”), to the Indenture, dated as of February
3, 2023 (the “2028 Original Indenture” and, as amended by the 2028 First Supplemental Indenture, the “2028 Indenture”),
by and between the Company and Wilmington Trust, National Association, a national banking association, as trustee (the “Trustee”),
relating to the Company’s 2.125% Convertible Senior Notes due 2028 (the “2028 Notes”), and (ii) the First Supplemental
Indenture, dated as of the Closing Date (the “2030 First Supplemental Indenture” and, together with the 2028 First Supplemental
Indenture, the “Supplemental Indentures”), to the Indenture, dated as of March 18, 2025, by and between the Company and the
Trustee (the “2030 Original Indenture” and, as amended by the 2030 First Supplemental Indenture, the “2030 Indenture”),
relating to the Company’s 1.875% Convertible Senior Notes due 2030 (the “2030 Notes” and, together with the 2028 Notes,
the “Notes”). The 2028 Original Indenture and the 2030 Original Indenture are referred to herein collectively as the “Original
Indentures” and the 2028 Indenture and the 2030 Indenture are referred to herein collectively as the “Indentures.” As
of the Closing Date, $116,284,000 aggregate principal amount of the 2028 Notes was outstanding and $1,000,000,000 aggregate principal
amount of the 2030 Notes was outstanding.
As a result of the Merger, and pursuant to the 2028 First Supplemental
Indenture and the 2030 First Supplemental Indenture, at and after the effective time of the Merger, the right to convert each $1,000 principal
amount of Notes was changed into a right to convert such principal amount of Notes into units of Reference Property (as defined in the
applicable Indenture), with each unit consisting solely of $127.00 in cash (an amount equal to the Merger Consideration (as defined below)).
As a result, the consideration due upon conversion of each $1,000 principal amount of Notes for which the Conversion Date (as defined
in the applicable Indenture) (occurs at or after the Effective Time (as defined below) will be solely cash in an amount equal to the applicable
Conversion Rate (as defined in the applicable Indenture) in effect on the Conversion Date (as may be increased by any Additional Shares
(as defined herein)), multiplied by $127.00.
The consummation of the Merger constitutes a Merger Event, a Fundamental
Change and a Make-Whole Fundamental Change (each as defined in the applicable Indenture) under each Indenture. The effective date of the
Merger Event, Fundamental Change and Make-Whole Fundamental Change in respect of the Notes is November 17, 2026 (the “Effective
Date”).
The Supplemental Indentures also amend the Original Indentures, as
applicable, to provide that (i) in the case of any Make-Whole Fundamental Change that also constitutes a Fundamental Change in respect
of which the Company is not required to offer to repurchase, or to repurchase, the applicable Notes, the Make-Whole Fundamental Change
Period (as defined in the applicable Indenture) will be the period from, and including, the effective date of such Make-Whole Fundamental
Change to, and including, the earlier of (x) the close of business on the 35th Trading Day (as defined in the applicable Indenture) immediately
following such effective date (or, if the Company gives notice to the holders of Notes of such transaction after such effective date,
the 35th Trading Day immediately following the date of such notice) and (y) the close of business on the second Scheduled Trading Day
(as defined in the applicable Indenture) immediately preceding the maturity date of the applicable Notes, and (ii) if a transaction constitutes
a Fundamental Change in respect of which the Company is not required to offer to repurchase, or to repurchase, the applicable Notes, all
or any portion of a holder’s applicable Notes may be surrendered for conversion at any time from, and including, the effective date
of such transaction to, and including, the earlier of (x) the close of business on the 35th Trading Day immediately following such effective
date (or, if the Company gives notice to the holders of Notes of such transaction after such effective date, the 35th Trading Day immediately
following the date of such notice) and (y) the close of business on the second Scheduled Trading Day immediately preceding the maturity
date of the applicable Notes.
The foregoing descriptions of the Indentures and the transactions contemplated
thereby are subject to and qualified in their entirety by reference to the full text of the Indentures. A copy of the 2028 Original Indenture
was filed as Exhibit 4.1 to the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission (the “SEC”)
on February 6, 2023, and a copy of the 2028 First Supplemental Indenture is filed as Exhibit 4.1 hereto. A copy of the 2030 Original Indenture
was filed as Exhibit 4.1 to the Current Report on Form 8-K filed by the Company with the SEC on March 19, 2025, and a copy of the 2030
First Supplemental Indenture is filed as Exhibit 4.2 hereto. Each of the 2028 Original Indenture, 2030 Original Indenture and Supplemental
Indentures is incorporated by reference into this Item 1.01. This Current Report on Form 8-K does not constitute an offer to tender for,
or purchase, or a solicitation of an offer to tender for, or purchase, any of the Notes or any other security.
Item 1.02 Termination of a Material Definitive
Agreement
The information set forth in the Introductory Note is incorporated
into this Item 1.02 by reference.
Termination of Existing Credit Agreement
In connection with the consummation of the Merger, on the Closing Date,
the Company repaid in full all outstanding obligations under the Credit Agreement, dated as of September 2, 2021 (as amended, restated,
supplemented or otherwise modified from time to time, the “Existing Credit Agreement”), by and among the Company, as parent,
Greatbatch Ltd., as borrower, Wells Fargo Bank, National Association, as administrative agent, and the other agents and lenders party
thereto, and terminated all commitments thereunder. Upon such repayment, all obligations under the Existing Credit Agreement, other than
certain continuing indemnity obligations, were released, satisfied and discharged in full and all security interests in the collateral
securing the loans were automatically terminated, released, satisfied and discharged.
Termination of Capped Call Transactions
On January 31, 2023, in connection with the pricing of the 2028 Notes,
the Company entered into capped call transactions (the “2028 Base Capped Call Transactions”) with certain financial institutions
(collectively, the “2028 Capped Call Counterparties”). On February 1, 2023, in connection with the exercise of the option
to purchase additional 2028 Notes by the initial purchasers of the 2028 Notes, the Company entered into additional capped call transactions
with the 2028 Capped Call Counterparties (the “Additional 2028 Capped Call Transactions” and, together with the 2028 Base
Capped Call Transactions, the “2028 Capped Call Transactions”).
On March 13, 2025, in connection with the pricing of the 2030 Notes,
the Company entered into capped call transactions (the “2030 Base Capped Call Transactions”) with certain financial institutions
(collectively, the “2030 Capped Call Counterparties”). On March 14, 2025, in connection with the exercise of the option to
purchase additional 2030 Notes by the initial purchasers of the 2030 Notes, the Company entered into additional capped call transactions
with the 2030 Capped Call Counterparties (the “Additional 2030 Capped Call Transactions” and, together with the 2030 Base
Capped Call Transactions, the “2030 Capped Call Transactions”). Each of the 2028 Capped Call Counterparties and 2030 Capped
Call Counterparties is referred to herein as a “Capped Call Counterparty” and, collectively, as the “Capped Call Counterparties,”
and the 2028 Capped Call Transactions and the 2030 Capped Call Transactions are referred to herein collectively as the “Capped Call
Transactions.”
In connection with the Merger, the Company entered into a termination
agreement with each Capped Call Counterparty (each, a “Termination Agreement” and, collectively, the “Termination Agreements”)
pursuant to which the Capped Call Transactions with such Capped Call Counterparty terminated upon the closing of the Merger in exchange
for an agreed-upon cash payment from such Capped Call Counterparty payable within one business day following the closing of the Merger.
The foregoing description of the termination of the Capped Call Transactions
is subject to and qualified in its entirety by reference to the full text of the Termination Agreements. A copy of the form of Termination
Agreement is filed as Exhibit 10.1 hereto and is incorporated into this Item 1.02 by reference.
Item 2.01 Completion of Acquisition or Disposition
of Assets
The information set forth in the Introductory Note is incorporated
herein by reference.
Pursuant to the Merger Agreement, at the effective time of the Merger
(the “Effective Time”), each share of Company common stock, par value $0.001 per share (the “Company Common Shares”),
outstanding immediately before the Effective Time (other than Company Common Shares owned by Parent, Merger Sub or any other subsidiary
of Parent) was converted into the right to receive $127.00 in cash (the “Merger Consideration”).
With respect to equity awards of the Company that were outstanding
as of immediately prior to the Effective Time, at the Effective Time, such awards were generally treated as follows:
| · | RSU Awards: Each restricted stock unit (“RSU”) award that was vested or vested upon the Transaction in accordance
with its terms was canceled and converted into the right to receive a cash amount equal to (i) the number of Company Common Shares subject
to such RSU award, multiplied by (ii) the Merger Consideration. Each unvested RSU award was canceled and converted into a cash amount
equal to (a) the number of Company Common Shares subject to such RSU award, multiplied by (b) the Merger Consideration, 50% of which will
be paid as soon as practicable after the Effective Time (assessed on a tranche-by-tranche basis) and the remaining 50% of which will be
paid subject to satisfaction of the same vesting conditions that applied to the corresponding RSU award, with vesting protections upon
a qualifying termination of employment. |
| · | PSU Awards: Each performance stock unit (“PSU”) award for which the
performance period was completed but that had not yet been settled was canceled and converted into the right to receive a cash
amount equal to (i) the number of Company Common Shares subject to such PSU award based on actual performance, multiplied by (ii)
the Merger Consideration. Each PSU award for which the performance period was not completed was canceled and converted into a cash
amount equal to (a) the number of Company Common Shares subject to such PSU award based on the greater of (x) target performance and
(y) actual performance, multiplied by (b) the Merger Consideration, 50% of which will be paid as soon as practicable after the
Effective Time (assessed on a tranche-by-tranche basis) and the remaining 50% of which will be paid subject to satisfaction of the
same service vesting conditions (without regard to any performance conditions) that applied to the corresponding PSU award, with
vesting protections upon a qualifying termination of employment. |
| · | Options: Each option to purchase Company Common Shares (“Company Option”) was fully vested and converted into the
right to receive a cash amount equal to (i) the excess, if any, of the Merger Consideration over the applicable exercise price per Company
Common Share subject to such award of Company Options, multiplied by (ii) the number of Company Common Shares subject to such Company
Option. If the exercise price of the Company Option was equal or greater to the Merger Consideration, such Company Option was cancelled
for no consideration. |
The foregoing summary of the Transaction does not purport to be complete
and is subject to, and qualified in its entirety by, the full text of the Merger Agreement, a copy of which was attached as Exhibit 2.1
to the Current Report on Form 8-K filed by the Company with the SEC on August 4, 2026 and is incorporated by reference as Exhibit 2.1
to this Current Report on Form 8-K, which is incorporated by reference herein.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing
The information set forth in the Introductory
Note and under Item 2.01 of this Current Report on Form 8-K is incorporated into this Item 3.01 by reference.
In connection with the consummation of the
Merger, the Company requested that the New York Stock Exchange (“NYSE”) suspend trading of the Company Common Shares effective
prior to the opening of trading on the Closing Date. On the Closing Date, following the Effective Time, the Company notified NYSE that
the Merger had been consummated and requested that NYSE file a Form 25 Notification of Removal from Listing and/or Registration with the
SEC to remove the Company Common Shares from listing on NYSE and deregister the Company Common Shares under Section 12(b) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). As a result, trading of the Company Common Shares was suspended prior
to the opening of trading on the Closing Date.
Upon effectiveness of the Form 25, the Company
intends to file a Certification and Notice of Termination on Form 15 with the SEC to deregister the Company Common Shares under Section
12(g) of the Exchange Act and suspend the Company’s reporting obligations under Sections 13 and 15(d) of the Exchange Act.
Item 3.03 Material Modifications to Rights of
Security Holders
The information set forth in the Introductory Note, Item 2.01, Item
3.01, Item 5.01 and Item 5.03 of this Current Report on Form 8-K is incorporated into this Item 3.03 by reference.
At the Effective Time, each holder of Company Common Shares as of immediately
prior to the Effective Time ceased to have any rights as a shareholder of the Company other than the right to receive the Merger Consideration
pursuant to the Merger Agreement.
Item 5.01 Changes in Control of Registrant
The information set forth in the Introductory Note, Item 2.01, Item
3.01, Item 3.03, Item 5.02 and Item 5.03 is incorporated into this Item 5.01 by reference.
As a result of the Merger, at the Effective Time, a change of control
of the Company occurred, and the Company became a wholly owned subsidiary of Parent. The total consideration payable in connection with
the Merger and pursuant to the Merger Agreement is approximately $5,400,000,000. The
funds used by Parent to consummate the Merger and complete the related transactions came from debt and equity financing, together with
cash on hand.
Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
The information set forth in the Introductory
Note and Item 2.01 of this Current Report on Form 8-K is incorporated into this Item 5.02 by reference.
As of the Effective Time, in connection with
the consummation of the Merger, all of the members of the board of directors of the Company (the “Board”) resigned as directors
of the Company and from any committees of the Board of which they were members. These resignations were not a result of any disagreement
between the Company and such directors on any matter relating to the Company’s operations, policies or practices. Pursuant to the
Merger Agreement, immediately after the Effective Time, the directors of Merger Sub as of the Effective Time, Max Lin and Hunter Craig,
became the directors of the surviving corporation.
Also, pursuant to the Merger Agreement, the
incumbent officers of the Company immediately prior to the Effective Time continued as officers of the surviving corporation immediately
after the Effective Time.
Item 5.03 Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year
The information set forth in the Introductory
Note and Item 2.01 of this Current Report on Form 8-K is incorporated into this Item 5.03 by reference.
Effective upon completion of the Merger, pursuant
to the Merger Agreement, the Company’s certificate of incorporation and bylaws were amended and restated in their entirety. Copies
of the Company’s amended and restated certificate of incorporation and amended and restated bylaws are attached as Exhibits 3.1
and 3.2, respectively, hereto and are incorporated herein by reference.
Item 7.01 Regulation FD Disclosure
The Merger constitutes a Merger Event, a Fundamental Change and a Make-Whole
Fundamental Change under the Indentures, effective as of the Effective Date.
Pursuant to the Indentures, holders may surrender all or any portion
of their Notes for conversion at any time from or after the Effective Date until the close of business (5:00 p.m. New York City time)
on January 8, 2027, the 35th Trading Day after the Effective Date (such period, the “Conversion Period”). The cash consideration
due upon conversion of each $1,000 in principal amount of Notes will be equal to the applicable Conversion Rate in effect on the relevant
Conversion Date (as may be increased by any additional shares pursuant to Section 14.03 of the applicable Indenture (“Additional
Shares”)) for each of the 2028 Notes and 2030 Notes, multiplied by the Merger Consideration of $127.00 per share.
The Conversion Rate for the 2028 Notes for which the relevant
notice of conversion is received by the conversion agent during the period which begins on, and includes, the Effective Date and
ends at the close of business (5:00 p.m. New York City time) on January 8, 2027, the 35th Trading Day after the Effective Date (the
“Make-Whole Fundamental Change Period”), will be increased by 0.2734
Additional Shares per $1,000 principal amount of 2028 Notes, to a total Conversion Rate of 11.7408
per $1,000 principal amount of 2028 Notes. Accordingly, a holder of 2028 Notes whose notice of conversion is received by the
conversion agent during the Make-Whole Fundamental Change Period will receive cash in the amount of approximately $1,491.08
per $1,000 principal amount of 2028 Notes converted, less any applicable withholding taxes.
The Conversion Rate for the 2030 Notes for which the relevant
notice of conversion is received by the conversion agent during the Make-Whole Fundamental Change Period will be increased by 1.4800
Additional Shares per $1,000 principal amount of 2030 Notes, to a total Conversion Rate of 8.1043 per $1,000 principal amount of
2030 Notes. Accordingly, a holder of 2030 Notes whose notice of conversion is received by the conversion agent during the Make-Whole
Fundamental Change Period will receive cash in the amount of approximately $1,029.25 per $1,000 principal amount of 2030 Notes
converted, less any applicable withholding taxes.
A notice of conversion received after the close of business (5:00 p.m.
New York City time) on January 8, 2027 will not be entitled to the Additional Shares and will instead be subject to the base Conversion
Rate per $1,000 principal amount of each of the 2028 Notes and 2030 Notes, which is 11.4681 and 6.6243, respectively.
Holders do not have the right to require the Company to repurchase
their Notes in connection with the Merger. The Indentures provide that the Company is not required to offer to repurchase, or to repurchase,
the Notes in respect of a Fundamental Change (i) that constitutes a Merger Event for which the Reference Property consists entirely of
cash in U.S. dollars; (ii) pursuant to which, immediately after the consummation of such transaction or event, the Notes become convertible
into consideration that consists solely of cash in U.S. dollars in an amount per $1,000 in principal amount of Notes that equals or exceeds
the Fundamental Change Repurchase Price (as defined in the applicable Indenture) per $1,000 in principal amount of Notes (calculated assuming
that such amount includes the maximum amount of accrued but unpaid interest payable as part of the Fundamental Change Repurchase Price
for such transaction or event); and (iii) in respect of which the Company timely sends the notice of such Fundamental Change, as required
pursuant to the Indentures. Each of the foregoing conditions has been satisfied with respect to each of the 2028 Notes and the 2030 Notes.
Accordingly, the Company is not making, and will not make, any offer to repurchase the Notes, and will not repurchase any Notes, in connection
with the Merger. Any Fundamental Change Repurchase Notice (as defined in the applicable Indenture) delivered by a holder will be of no
effect.
On November 17, 2026, the Company provided holders of the 2028 Notes
and the 2030 Notes with notices of the applicable Supplemental Indenture, Make-Whole Fundamental Change, Fundamental Change and right
to convert pursuant to the applicable Indenture.
On November 17, 2026, the Company issued a press release providing
notice of the Effective Date of a Make-Whole Fundamental Change, Fundamental Change and right to convert pursuant to each of the Indentures.
A copy of the press release is attached hereto as Exhibit 99.1.
On November 17, 2026, the Company issued a press
release announcing consummation of the transaction between the Company and Parent. A copy of the press release is attached hereto as Exhibit
99.2.
The information included in this Item 7.01 of this Current Report on
Form 8-K, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed to be filed for the purposes
of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by
reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in such filing.
Item 9.01 Financial Statements
and Exhibits
(d) Exhibits
| |
No. |
Document Description |
| |
2.1+^ |
Agreement and Plan of Merger, by and among Integer Holdings Corporation, Armstrong Parent, Inc. and Armstrong Bidco, Inc., dated as of August 2, 2026 (incorporated herein by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K, initially filed with the SEC on August 4, 2026) |
| |
3.1 |
Amended and Restated Certificate of Incorporation of Integer Holdings Corporation |
| |
3.2 |
Amended and Restated Bylaws of Integer Holdings Corporation |
| |
4.1 |
2028 Notes First Supplemental Indenture, dated November 17, 2026, by and between Integer Holdings Corporation
and Wilmington Trust, National Association, as trustee |
| |
4.2 |
2030 Notes First Supplemental Indenture, dated November 17, 2026, by and between Integer Holdings Corporation and Wilmington Trust, National Association, as trustee |
| |
10.1 |
Form of Termination Agreement (2028 Notes), between Integer Holdings Corporation and the applicable Capped Call Counterparty |
| |
10.2 |
Form of Termination Agreement (2030 Notes), between Integer Holdings Corporation and the applicable Capped Call Counterparty |
| |
99.1 |
Press release, dated November
17, 2026 |
| |
99.2 |
Press release, dated November 17, 2026 |
| |
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
+ In accordance with Item 601(a)(5) of Regulation
S-K, certain schedules to this agreement have been omitted (as marked by asterisks).
^ In accordance with Item 601(b)(2) of Regulation
S-K, portions of the exhibit have been omitted because it is both not material and is of the type the registrant treats as private or
confidential.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: November 17, 2026 |
/s/ Lindsay K. Blackwood |
| |
Name: Lindsay K. Blackwood |
| |
Title: General Counsel & Secretary |
Exhibit 99.1


FOR IMMEDIATE RELEASE
Integer Holdings Corporation Provides Notice
of
Make-Whole Fundamental Change, Fundamental Change
and Right to Convert to
Holders of its 2.125% Convertible Senior Notes
due 2028 and
1.875% Convertible Senior Notes due 2030 in Connection
with Completed Merger
PLANO, Texas, Nov. 17, 2026 (GLOBE NEWSWIRE)
-- Integer Holdings Corporation (“Integer” or the “Company”), a leading medical device contract development
and manufacturing organization, today delivered notices (each, a “Notice” and together, the “Notices”) to holders
of its 2.125% Convertible Senior Notes due 2028 (the “2028 Notes”) and its 1.875% Convertible Senior Notes due 2030 (the “2030
Notes” and, together with the 2028 Notes, the “Notes”), pursuant to the Indenture, dated as of February 3, 2023, governing
the 2028 Notes, and the Indenture, dated as of March 18, 2025, governing the 2030 Notes (each, an “Indenture”), in each case
between the Company and Wilmington Trust, National Association, as trustee (the “Trustee”), that a Make-Whole Fundamental
Change and a Fundamental Change (each as defined in the applicable Indenture) occurred under each Indenture on November 17, 2026
(the “Effective Date”).
On the Effective Date, the Company completed its
previously announced merger (the “Merger”) with Armstrong Bidco, Inc., a wholly owned subsidiary of Armstrong Parent, Inc.
(“Parent”), pursuant to the Agreement and Plan of Merger, dated as of August 2, 2026. As a result of the Merger, the Company
became a wholly owned subsidiary of Parent, and each outstanding share of the Company’s common stock (other than certain excluded
shares) was converted into the right to receive $127.00 in cash, without interest (the “Merger Consideration”).
Notice of Make-Whole Fundamental Change Effective
Date
Pursuant to each Indenture, holders may convert
their Notes in connection with the Merger at any time from, and including, the Effective Date to, and including, the close of business
(5:00 p.m., New York City time) on January 8, 2027, which is the thirty-fifth (35th) Trading Day immediately following
the Effective Date (the “Conversion Period”). Holders whose Notice of Conversion is received by the conversion agent during
the period from, and including, the Effective Date to, and including, 5:00 p.m., New York City time, on January 8, 2027 (the “Make-Whole
Fundamental Change Period”), will be entitled to an increased Conversion Rate, as follows:
2028 Notes. The consideration due upon
conversion during the Make-Whole Fundamental Change Period will be cash of approximately $1,491.08 per $1,000 principal amount of
2028 Notes, based on a Conversion Rate of 11.7408 (the Conversion Rate of 11.4681 in effect immediately prior to the Merger, plus
0.2727 Additional Shares), multiplied by $127.00. A holder whose Notice of Conversion is received after the Make-Whole Fundamental
Change Period ends will receive cash of $1,456.45 per $1,000 principal amount of 2028 Notes.
2030 Notes. The consideration due upon
conversion during the Make-Whole Fundamental Change Period will be cash of approximately $1,029.25 per $1,000 principal amount of
2030 Notes, based on a Conversion Rate of 8.1043 (the Conversion Rate of 6.6243 in effect immediately prior to the Merger, plus
1.4800 Additional Shares), multiplied by $127.00. A holder whose Notice of Conversion is received after the Make-Whole Fundamental
Change Period ends will receive cash of $841.29 per $1,000 principal amount of 2030 Notes.
Upon the expiration of the Make-Whole Fundamental
Change Period, the Conversion Rate for each series of Notes will automatically, without further notice, return to the Conversion Rate
in effect immediately prior to the Merger. After the Conversion Period ends, the Notes will no longer be convertible solely on account
of the Merger and will be convertible only under the circumstances and during the periods set forth in the applicable Indenture.
Notice of Fundamental Change; No Repurchase
Right
Under Section 15.02(e) of each Indenture, the Company
is not required to offer to repurchase, or to repurchase, the Notes in connection with the Merger, because the Merger is a Merger Event
for which the Reference Property consists solely of cash in U.S. dollars, the cash amount into which the Notes became convertible immediately
after the Merger equals or exceeds the maximum Fundamental Change Repurchase Price for each series, and the Company has timely delivered
the required notice. Accordingly, holders do not have the right to require the Company to repurchase their Notes in connection with the
Merger.
Holders of Notes should read the applicable Notice
carefully, as it contains important information regarding the procedures and timing for the exercise of conversion rights. The Notices
are available through The Depository Trust Company or by requesting a copy from Wilmington Trust, National Association, which is serving
as the conversion agent, at:
Wilmington Trust, National Association
1310 Silas Deane Highway
Wethersfield, CT 06109
Attn: Integer Holdings Corporation Notes Administrator
None of the Company, Parent, their respective boards
of directors or employees, or the Trustee has made or is making any representation or recommendation to any holder as to whether to convert
or refrain from converting its Notes.
This press release is for informational purposes
only and is not an offer to purchase, or a solicitation of an offer to sell, any securities, nor shall there be any purchase or sale of
securities in any state or jurisdiction in which such offer, solicitation, purchase or sale would be unlawful.
About Integer®
Integer Holdings Corporation is one of the largest
medical device contract development and manufacturing organizations (CDMOs) in the world, serving the cardio and vascular, neuromodulation,
and cardiac rhythm management markets. As a strategic partner of choice, we advance the goals of our medical device customers through
industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. The company’s
brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.
Investor Relations:
Kristen Stewart
kristen.stewart@integer.net
551-337-3973
Exhibit 99.2
Integer Announces Completion of Acquisition
by KKR
~ Positioned to Advance Innovation and Growth
in Support of Customers and Patients ~
PLANO, Texas, November 17, 2026
(GLOBE NEWSWIRE) – Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading
global medical device contract development and manufacturing organization (CDMO), today announced the completion of its acquisition by
an affiliate of investment funds managed by KKR, a leading global investment firm, in a transaction valued at an enterprise value of
approximately $5.7 billion (the “Transaction”).
The Transaction was announced on August 3, 2026, and was approved by
Integer stockholders on October 21, 2026. Under the terms of the Transaction, Integer stockholders will receive $127 per share in cash.
With the completion of the Transaction, Integer’s common stock has ceased trading and will no longer be listed on the New York Stock
Exchange.
“Today marks an exciting new chapter for Integer, our associates,
customers, and the patients we collectively serve,” said Payman Khales, Integer’s President and CEO. “Integer has built
a reputation as a trusted partner to the world’s leading medical device companies and emerging innovators through our relentless
focus on quality, customer service, and innovation. Together with KKR, we are well positioned to accelerate our growth strategy, further
invest in our people, capabilities and technologies, and continue delivering the expertise and solutions that help our customers bring
life-enhancing and life-saving devices to patients around the world.”
“We are pleased to officially welcome Integer to the KKR portfolio
and look forward to building on the Company’s strong foundation alongside Payman and the management team,” said Max Lin, Partner
at KKR. “We see significant opportunities to leverage our resources and expertise to support Integer’s next phase of growth,
expand its capabilities and strengthen its position as a trusted partner to the global medical device industry.”
About Integer®
Integer Holdings Corporation is one of the largest medical device
contract development and manufacturing organizations (CDMOs) in the world, serving the cardio and vascular, neuromodulation, and cardiac
rhythm management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading
engineering and manufacturing, with a relentless commitment to quality, service, and innovation. The Company’s brands include Greatbatch
Medical® and Lake Region Medical®. Additional information is available at www.integer.net.
About KKR
KKR is a leading global investment firm that offers alternative asset
management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient
and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities.
KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds.
KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial
Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional
information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com.
For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.
Contacts
Integer
Media Relations:
Misty Tippen
misty.tippen@integer.net
469-536-6702
Investor Relations:
Kristen Stewart
kristen.stewart@integer.net
551-337-3973
KKR
Media:
media@kkr.com
Cautionary Statement Regarding Forward-Looking
Statements
Some of the statements contained in this communication
and other written and oral statements made from time to time by us and our representatives are not statements of historical or current
fact. As such, they are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby under the Private
Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current expectations, and these statements
are subject to known and unknown risks, uncertainties and assumptions. Forward-looking statements include, but are not limited to, statements
relating to: potential litigation relating to the Transaction that has been or could be instituted against the parties to the Transaction,
or their respective directors, managers, or officers, including the effects of any outcomes related thereto; our goals, plans, and strategic
initiatives; long-term growth prospects; other events, conditions or developments that will or may occur in the future; and the timing
of any of the foregoing. You can identify forward-looking statements by terminology such as “may,” “will,” “should,”
“could,” “expects,” “intends,” “plans,” “anticipates,” “believes,”
“estimates,” “predicts,” “projects,” “forecast,” “outlook,” “assume,”
“potential” or “continue” or variations or the negative counterparts of these terms or other comparable terminology.
These statements are only predictions and are not guarantees of future performance, and investors should not place undue reliance on forward-looking
statements as predictive of future results. Actual events or results may differ materially from those stated or implied by these forward-looking
statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below. All forward-looking
statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary factors and
by others contained throughout this communication.
Forward-looking statements by their nature address
matters that are, to different degrees, uncertain, such as statements regarding the Transaction. All such forward-looking statements are
based upon current plans, estimates, expectations, opportunities and ambitions that are subject to risks, uncertainties, assumptions,
and other important factors, many of which are beyond the control of the Company, that could cause actual results to differ materially
from those expressed in such forward-looking statements. Key factors that could cause actual results to differ materially include, but
are not limited to, risks related to disruption of management time from ongoing business operations due to the Transaction; the risk that
the Transaction could have an adverse effect on the parties’ business relationships and business generally, including the ability
of the Company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers, and
on their operating results and businesses generally; the risk of unforeseen or unknown liabilities; customer, regulatory and other stakeholder
approvals and support; the risk of unexpected future capital expenditures; the risk of potential litigation relating to the Transaction
that has been or could be instituted against the Company or its directors and/or officers; the risk associated with third-party contracts
containing material consent, anti-assignment, transfer or other provisions that may be related to the Transaction which are not waived
or otherwise satisfactorily resolved; significant costs, or expenses incurred in connection with the Transaction; the risk of various
events that could disrupt operations, including pandemics, epidemics or other public health crises or severe weather (such as droughts,
floods, avalanches and earthquakes), cybersecurity attacks, security threats and governmental response to them, and technological changes;
the risks of labor disputes, changes in labor costs and labor difficulties; and the risks resulting from other effects of industry, market,
economic, legal or legislative, political or regulatory conditions outside of the Company’s control. All such factors are difficult
to predict and are beyond our control, including those detailed in the Company’s Annual Report on Form 10-K for the fiscal year
ended December 31, 2025, which was filed with the Securities and Exchange Commission (the “SEC”) on February 23, 2026, the
Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended October 2, 2026, which was filed with the SEC on October 29,
2026, the Company’s definitive proxy statement filed with the SEC on September 14, 2026, as supplemented, and other documents subsequently
filed by the Company with the SEC. The Company’s forward-looking statements are based on assumptions that the Company believes to
be reasonable but that may not prove to be accurate. Other unpredictable factors not discussed in this communication could also have material
adverse effects on forward-looking statements. The Company does not assume an obligation to update any forward-looking statements, except
as required by applicable law. These forward-looking statements speak only as of the date hereof.